.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Mallinckrodt
Deloitte
Express Scripts
Johnson and Johnson
Harvard Business School
Fuji
Chinese Patent Office
Farmers Insurance
Healthtrust

Generated: September 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 200654

« Back to Dashboard
NDA 200654 describes ANASTROZOLE, which is a drug marketed by Sandoz, Natco Pharma Ltd, Zydus Pharms Usa Inc, Synthon Pharms, Kremers Urban Pharms, Dr Reddys Labs Ltd, Impax Labs Inc, Santos Biotech, Mylan, Apotex Inc, Teva Pharms, Cipla Ltd, Accord Hlthcare, Sun Pharm Inds Ltd, Watson Labs Teva, West-ward Pharms Int, and Fresenius Kabi Oncol, and is included in seventeen NDAs. It is available from thirty-one suppliers. Additional details are available on the ANASTROZOLE profile page.

The generic ingredient in ANASTROZOLE is anastrozole. There are twenty-four drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the anastrozole profile page.

Summary for NDA: 200654

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antineoplastics
Formulation / Manufacturing:see details

Pharmacology for NDA: 200654

Mechanism of ActionAromatase Inhibitors

Suppliers and Packaging for NDA: 200654

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ANASTROZOLE
anastrozole
TABLET;ORAL 200654 ANDA Golden State Medical Supply, Inc. 60429-286 60429-286-30 30 TABLET, FILM COATED in 1 BOTTLE (60429-286-30)
ANASTROZOLE
anastrozole
TABLET;ORAL 200654 ANDA Golden State Medical Supply, Inc. 60429-286 60429-286-90 90 TABLET, FILM COATED in 1 BOTTLE (60429-286-90)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength1MG
Approval Date:May 11, 2012TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Express Scripts
Julphar
Fuji
Accenture
Healthtrust
UBS
Chubb
Citi
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot